Literature DB >> 1453578

Bradykinin-mediated effects of ACE inhibition.

I Gavras1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1453578     DOI： 10.1038/ki.1992.383

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  15 in total

Review 1.  ACE inhibitors and proteinuria.

Authors:  R T Gansevoort; D de Zeeuw; P E de Jong
Journal:  Pharm World Sci       Date:  1996-12

Review 2.  Renin inhibitors: cardiovascular drugs of the future?

Authors:  J M Wood; P Close
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

3.  Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy.

Authors:  A J Cowley; B L Wiens; R Segal; M W Rich; N C Santanello; E J Dasbach; B Pitt
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 4.  A review of calcium channel antagonists in the treatment of pediatric hypertension.

Authors:  Shobha Sahney
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 5.  Angiotensin receptor blockers in diabetic nephropathy.

Authors:  D A Price; N K Hollenberg
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 6.  Angiotensin II receptor antagonists in chronic heart failure: where do they fit?

Authors:  Andrew R Houghton
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.

Authors:  B Pitt; P Chang; P B Timmermans
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

Review 8.  Treatment of hypertension in children.

Authors:  A R Sinaiko
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

Review 9.  Clinical impact of renin-angiotensin system blockade: angiotensin-converting enzyme inhibitors vs. angiotensin receptor antagonists.

Authors:  Joseph L Izzo; Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

Review 10.  Drugs that interrupt the renin-angiotensin system should be among the preferred initial drugs to treat hypertension.

Authors:  Michael A Moore
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Mar-Apr       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.